John Hussman's PAHC Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 42,000 shares of Phibro Animal Health Corporation (PAHC) worth $2.32 M, representing 0.50% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in PAHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 105,000 shares. Largest reduction occurred in Q2 2025, reducing 42,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Phibro Animal Health Corporation (PAHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Phibro Animal Health Corporation (PAHC) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | -42,000 | Reduce 50.00% | 42,000 | $40.46 |
| Q2 2025 | -42,000 | Reduce 33.33% | 84,000 | $25.54 |
| Q1 2025 | +21,000 | Add 20.00% | 126,000 | $21.36 |
| Q4 2024 | +105,000 | New Buy | 105,000 | $21.00 |
| Q2 2023 | -26,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +26,000 | New Buy | 26,000 | $20.42 |
John Hussman's Phibro Animal Health Corporation Investment FAQs
John Hussman first purchased Phibro Animal Health Corporation (PAHC) in Q4 2021, acquiring 26,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Phibro Animal Health Corporation (PAHC) for 13 quarters since Q4 2021.
John Hussman's largest addition to Phibro Animal Health Corporation (PAHC) was in Q4 2024, adding 105,000 shares worth $2.2 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 42,000 shares of Phibro Animal Health Corporation (PAHC), valued at approximately $2.32 M.
As of the Q1 2026 filing, Phibro Animal Health Corporation (PAHC) represents approximately 0.50% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Phibro Animal Health Corporation (PAHC) was 126,000 shares, as reported at the end of Q1 2025.